Cancer Research KI Workshops
KI-Mayo Seminars and Workshops 2021
In 2019, the Karolinska Institutet and Mayo Clinic celebrated 25 years of fruitful scientific collaboration and exchange. As part of this collaborative effort seminars and workshops will be held periodically in order to inform our cancer research community of ongoing/future work as well as grant announcements, 'match' researchers for specific grant calls and much more!
Next joint symposia on the 7th of October 16.00-19.00 (Swedish time) via zoom
The second joint Mayo Clinic Cancer Center and Cancer Research KI symposia will be arranged on the 7th of October 2021 at 16.00-19.00. This will be a zoom event and please email Johanna Furuhjelm at email@example.com to register your participation. A detailed programme will be announced shortly.
On the 13th January 2021, at 15.00-18.00 (Swedish time), Mayo Clinic Cancer Center and Cancer Research KI held our first joint symposium to inform respective cancer research communities about ongoing breast cancer research. The purpose of this event is also for researchers in the breast cancer area to meet as well as to stimulate collaboration in this area between KI and Mayo Clinic Cancer Center.
To register for this virtual event please email: Johanna Furuhjelm (Research Coordinator for Cancer Research KI) at firstname.lastname@example.org
Cancer workshop for patient organisations/Cancer workshop för patientorganisationer 31st Mars/March 2021
*This event will be held on 31st March 2021 via ZOOM and all presentations/discussions will be held in Swedish.*
This joint workshop between Cancer Research KI and RCC Stockholm-Gotland, will aim to address opportunities for interaction and communication between different patient organisations, researchers and the general public. All presentations and discussions will be in Swedish.
To register for the workshop contact:/ Anmälning sker genom mail till: email@example.com.
Zoom link to the event will be sent to the registered participants on the 30 March/ Länk till zoom eventet skickas ut till alla anmälda den 30 mars.
Programme for patient organisation workshop
Nordic GAP workshop 2017
The first Nordic Global Academic Program (NGAP) Workshop was hosted by Rigshospitalet in Copenhagen on Oct 12th, 2017 bringing together the Nordic Sister Institutions and MD Anderson Cancer Center for lively discussions and interaction with the goal of fostering collaborations on clinical trials.
The program featured prominent experts on cancer registries, data handling, bio banking, advances in precision medicine and cancer treatment from
- Oslo University Hospital
- Cancer Registry of Norway
- Karolinska Institutet
- MD Anderson Cancer Center
Houston, TX, USA
MD Anderson - Karolinska Institutet workshop
Karolinska Institutet is a sister institution to the MD Anderson Cancer Center, Huston, Texas, since 2013.
The MD Anderson - KI workshop was held on Sept 24th, 2017 at Djurönäset to bring together scientists from both institutions further encouraging interaction and collaboration between the research sites.
We were proud to recently celebrate the renewal of the sister institution agreement as part of the Global Academic Program (GAP) conference in May, 2018.
CRISPR/Cas9 2nd workshop
The popular CRISPR/Cas9 workshop was held for a second time January 12-13, 2015 at KI Science Park.
- Feng Zhang, Broad Institute of MIT
- Oscar Fernandez-Capetillo, KI
- Philip Hublitz, University of Oxford, WIMM
- Thoru Pederson, University of Massachusetts Medical School
- Vera Grinkevich, Wellcome Trust Sanger Institute
KI-Roche Oncology Workshop
The first KI-Roche Oncology workshop was held October 19-20, 2015 at Nobel Forum. The ambitions and ongoing efforts under the Master Collaboration Agreement (MCA, active since Dec. 2014) were introduced. Short scientific presentations were held by both parties, laying ground for discussions regarding possibilities for joint projects.
CRISPR/Cas9 1st workshop
The first StratCan workshop was held January 7-8, 2015 on CRISPR/Cas9. The workshop was a theory & hands on workshop teaching how to design and use the CRISPR/Cas9 system for in vitro (cells) and in vivo (mice) applications.
Invited speakers were leading researchers involved in developing this technique: Feng Zhang, Haoyi Wang, Kosuke Yusa and Vera Grinkevich. The workshop received great interest with over 70 applicants and the number of participants was therefore expanded from 30 to 45, including also international participants from Germany, France and the UK.
A joint 1-day symposium by BIOCON and KI on novel cancer therapy, was held at Nobel Forum April 25, 2014.
BIOCON, the Medicinal Bioconvergence Research Center (Director Sunghoon Kim) is based at Seoul National University and focuses on novel therapeutic target discovery and validation that can be further explored by the industry.